Lonza’s approach of early process engagement also accelerates the path to cGMP maturity and contributes to efficient, cost-effective manufacturing of mRNA vaccines and therapeutics.

The mRNA drug substance then undergoes in-process and release testing via a comprehensive suite of in-house analytical characterization services to assess identity, purity, quantity, potency, and ...

Vaccines to prevent SARS-CoV-2 infection were not the first attempt at utilizing the promise of mRNA in a therapeutic setting. | Every mRNA manufacturing process step adds complexity and cost, so ...

That dismays infectious disease experts who note that mRNA allows faster production of shots than older vaccine-production ... Using mRNA is a faster process. The “m” stands for messenger, meaning ...

Represents commitment to global efforts against COVID-19 with optimized mRNA production using proprietary chromatographic columns and process Manufacturing process successful in production of ...

Ginkgo and Aldevron's VCE manufacturing approach is more than 10 times more efficient than the prior process, the partners said in a release.

Join the 3rd mRNA Process Development Summit Europe to connect with over 100 experts in upstream and downstream process development.

The 3rd mRNA Process Development and Manufacturing Summit returns to Boston this September, poised to help you implement high throughput process development, scale-up mRNA synthesis and purification, ...